✦ LIBER ✦

Certolizumab pegol: BLA accepted for filing and review

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ecallantide BLA accepted for priority re

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Efficacy and Safety of Certolizumab Pego

✍ Wei Da, Jinshui Zhu, Long Wang, Yunmin Lu 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 494 KB

Cochrane Database of Systematic Reviews

✍ Ruiz Garcia, Vicente 📂 Article 📅 2009 🏛 John Wiley & Sons, Ltd ⚖ 159 KB

PGI24 COST UTILITY ANALYSIS OF CERTOLIZU

✍ B Wu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Books accepted for review

📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Books accepted for review

📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB